MedTrace Logo

A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)

NCT00737165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1951060

Last updated 2013-10-31

No results posted yet for this study

Summary

1. The primary goal for this study is to examine the effectiveness of community-based multimodal intervention program for suicide prevention in relatively high suicide rate region compared to control region.
2. The secondary goal for this study is to explore the effectiveness of community-based multimodal intervention program for suicide prevention in the highly populated regions. In addition, we examine the effectiveness of the prevention program in the all regions combined.

Conditions

  • Suicide

Interventions

BEHAVIORAL

Multimodal suicide prevention program

A community intervention of multimodal suicide prevention program includes following components: 1. Building support networks for suicide prevention and mental health promotion in public health system 2. Primary prevention of suicide and suicide related behaviors 3. Secondary prevention of suicide and suicide related behaviors 4. Tertiary prevention; after care for suicide survivors 5. Suicide prevention targeting for people with substance/alcohol- related disorders , schizophrenia and other mental health disorders 6. Suicide prevention targeting for people with work-related problems

BEHAVIORAL

Suicide prevention program as usual

Usual suicide prevention program

Sponsors & Collaborators

  • National Center of Neurology and Psychiatry, Japan

    collaborator OTHER

  • Japan Foundation for Neuroscience and Mental Health

    lead OTHER

Principal Investigators

  • Yutaka Ono, MD,PhD · Keio University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-12-31
Completion
2011-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737165 on ClinicalTrials.gov